Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

The use of group sequential designs with common competing risks tests.

Logan BR, Zhang MJ.

Stat Med. 2013 Mar 15;32(6):899-913. doi: 10.1002/sim.5597. Epub 2012 Sep 4.

2.

Group sequential methods for cluster randomization trials with binary outcomes.

Zou GY, Donner A, Klar N.

Clin Trials. 2005;2(6):479-87.

PMID:
16422308
4.
5.

Choice and interpretation of statistical tests used when competing risks are present.

Dignam JJ, Kocherginsky MN.

J Clin Oncol. 2008 Aug 20;26(24):4027-34. doi: 10.1200/JCO.2007.12.9866.

6.

Analysis and design of randomised clinical trials involving competing risks endpoints.

Tai BC, Wee J, Machin D.

Trials. 2011 May 19;12:127. doi: 10.1186/1745-6215-12-127.

7.

Planning and evaluating clinical trials with composite time-to-first-event endpoints in a competing risk framework.

Rauch G, Beyersmann J.

Stat Med. 2013 Sep 20;32(21):3595-608. doi: 10.1002/sim.5798. Epub 2013 Apr 2.

PMID:
23553898
8.

Interim analyses and early termination of clinical trials.

Choi SC.

J Biopharm Stat. 1997 Nov;7(4):533-43. Review.

PMID:
9358327
9.

Exploring the benefits of adaptive sequential designs in time-to-event endpoint settings.

Emerson SC, Rudser KD, Emerson SS.

Stat Med. 2011 May 20;30(11):1199-217. doi: 10.1002/sim.4156. Epub 2010 Dec 29.

10.

Voriconazole versus amphotericin B in cancer patients with neutropenia.

Jørgensen KJ, Gøtzsche PC, Johansen HK.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD004707. Review. Update in: Cochrane Database Syst Rev. 2014;2:CD004707.

PMID:
16437492
11.

Competing time-to-event endpoints in cardiology trials: a simulation study to illustrate the importance of an adequate statistical analysis.

Rauch G, Kieser M, Ulrich S, Doherty P, Rauch B, Schneider S, Riemer T, Senges J.

Eur J Prev Cardiol. 2014 Jan;21(1):74-80. doi: 10.1177/2047487312460518. Epub 2012 Sep 10.

PMID:
22964966
12.

A practical simulation method to calculate sample size of group sequential trials for time-to-event data under exponential and Weibull distribution.

Jiang Z, Wang L, Li C, Xia J, Jia H.

PLoS One. 2012;7(9):e44013. doi: 10.1371/journal.pone.0044013. Epub 2012 Sep 5.

13.

On efficient two-stage adaptive designs for clinical trials with sample size adjustment.

Liu Q, Li G, Anderson KM, Lim P.

J Biopharm Stat. 2012;22(4):617-40. doi: 10.1080/10543406.2012.678226.

PMID:
22651105
14.

Group sequential, sample size re-estimation and two-stage adaptive designs in clinical trials: a comparison.

Shih WJ.

Stat Med. 2006 Mar 30;25(6):933-41. No abstract available.

PMID:
16220505
15.

Information-based sample size re-estimation in group sequential design for longitudinal trials.

Zhou J, Adewale A, Shentu Y, Liu J, Anderson K.

Stat Med. 2014 Sep 28;33(22):3801-14. doi: 10.1002/sim.6192. Epub 2014 May 4.

PMID:
24797715
16.

Optimizing trial design in pharmacogenetics research: comparing a fixed parallel group, group sequential, and adaptive selection design on sample size requirements.

Boessen R, van der Baan F, Groenwold R, Egberts A, Klungel O, Grobbee D, Knol M, Roes K.

Pharm Stat. 2013 Nov-Dec;12(6):366-74. doi: 10.1002/pst.1599. Epub 2013 Sep 23.

PMID:
24214896
17.

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial.

Kullberg BJ, Sobel JD, Ruhnke M, Pappas PG, Viscoli C, Rex JH, Cleary JD, Rubinstein E, Church LW, Brown JM, Schlamm HT, Oborska IT, Hilton F, Hodges MR.

Lancet. 2005 Oct 22-28;366(9495):1435-42.

PMID:
16243088
18.

Evaluating health outcomes in the presence of competing risks: a review of statistical methods and clinical applications.

Varadhan R, Weiss CO, Segal JB, Wu AW, Scharfstein D, Boyd C.

Med Care. 2010 Jun;48(6 Suppl):S96-105. doi: 10.1097/MLR.0b013e3181d99107. Review.

PMID:
20473207
19.

Conditional power calculations for clinical trials with historical controls.

Korn EL, Freidlin B.

Stat Med. 2006 Sep 15;25(17):2922-31.

PMID:
16479548
20.

Group sequential and discretized sample size re-estimation designs: a comparison of flexibility.

Wu X, Cui L.

Stat Med. 2012 Oct 30;31(24):2844-57. doi: 10.1002/sim.5395. Epub 2012 Jun 26.

PMID:
22733405
Items per page

Supplemental Content

Write to the Help Desk